The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2024 | The role of the patient in decision-making in R/R follicular lymphoma
Lorna Warwick, BSc, Lymphoma Coalition, Toronto, Canada, emphasizes the importance of shared decision-making in relapsed/refractory (R/R) follicular lymphoma (FL). Ms Warwick highlights that physicians should actively seek out patients’ input and preferences and discuss these with them in detail, taking into account each individual’s unique experience. An ongoing conversation about treatment options is crucial as patients’ needs and priorities may change over time, and it’s essential to revisit and adapt the discussion as their lives and disease evolve. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
